Pinato, David J.
Mauri, Francesco A.
Spina, Paolo
Cain, Owen
Siddique, Abdul
Goldin, Robert
Victor, Stephane
Pizio, Corinna
Akarca, Ayse U.
Boldorini, Renzo L.
Mazzucchelli, Luca
Black, James R. M.
Shetty, Shishir
Marafioti, Teresa
Sharma, Rohini
Funding for this research was provided by:
Academy of Medical Sciences (SGL013/1021)
Cancer Research UK (C57701/A26137)
Wellcome Trust (PS3416)
Article History
Received: 27 January 2019
Revised: 26 March 2019
Accepted: 9 April 2019
First Online: 7 May 2019
Competing interests
: The authors declare no competing interests.
: This study was in part funded by a Clinical Lecturer Starter Grant awarded by the Academy of Medical Sciences (AMS Grant ID SGL013/1021) to D.J.P. The Starter Grant is jointly funded by the AMS, Wellcome Trust, Medical Research Council, British Heart Foundation, Arthritis Research UK, the Royal College of Physicians and Diabetes UK. This study was also supported by project grant funding from Cancer Research UK for the immune phenotyping of HCC (Postdoctoral Bursary Grant Ref. C57701/A26137). The funders had no role in the design, conduction or interpretation of the results of this study.
: Ethical approval for the use of retrospective clinical samples was granted by the Imperial College Tissue Bank (Authorisation no. 12/WA/0196/R16005). The study was performed in accordance with the Declaration of Helsinki.
: Primary research data are presented in a summative fashion in the manuscript. No publicly available datasets have been generated as part of this work.